Danny Hsu: The 2nd THANZ Webinar Series To Bring Timely Updates in Thrombosis and Hemostasis
Danny Hsu, President of THANZ, Director of Therapeutic Apheresis, Immune and Obstetric Haematology at South Western Sydney Local Health District, shared on LinkedIn:
”SAVE THE DATE- THANZ webinar ‘Creepy Crawlies’
Wed 1st April 6:30-8pm AEDT
We’re excited to announce the second of our Thrombosis and Haemostasis Society of Australia and New Zealand Education Committee webinar series, designed to bring you timely insights, practical knowledge, and direct access to experts in thrombosis and hemostasis.
Our next session, ‘Creepy Crawlies’, will take place on Wednesday 1st April from 6:30-8pm AEDT
Featured speakers:
- Prof Glenn King (University of Queensland)
- Prof Geoff Isbister (University of Newcastle)
- 3rd Speaker – TBC
The webinar will cover spider venom treatment for stroke, the treatment of snakebite coagulopathy and research on an anticoagulant derived from tsetse fly protein.
Attendance is free and open to all, so please share with your colleagues; however, you will need to register.
Save the date now – more details and how to register will follow shortly
We look forward to seeing you online!!!”

Stay updated with Hemostasis Today.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis